tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bristol Myers commitment a reminder of Veeva’s progress, says Stifel
PremiumThe FlyBristol Myers commitment a reminder of Veeva’s progress, says Stifel
1M ago
Bayer announces progress for two potential therapies for Parkinson’s disease
Premium
The Fly
Bayer announces progress for two potential therapies for Parkinson’s disease
1M ago
Oppenheimer maintains bullish stance on Corteva following split reports
Premium
The Fly
Oppenheimer maintains bullish stance on Corteva following split reports
2M ago
Bayer ‘making headway’ on improving profitability in agricultural business
PremiumThe FlyBayer ‘making headway’ on improving profitability in agricultural business
3M ago
Bayer reports Q2 core EPS EUR 1.23 vs. EUR 0.94 last year
Premium
The Fly
Bayer reports Q2 core EPS EUR 1.23 vs. EUR 0.94 last year
3M ago
Bayer affirms aim to ‘significantly’ contain litigation risk by end of 2026
Premium
The Fly
Bayer affirms aim to ‘significantly’ contain litigation risk by end of 2026
3M ago
RedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
PremiumThe FlyRedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
4M ago
BridgeBio raises $300M via parital capped monetization of European royalty
Premium
The Fly
BridgeBio raises $300M via parital capped monetization of European royalty
4M ago
Orion says Bayer reports CHMP recommends third indication for darolutamide
Premium
The Fly
Orion says Bayer reports CHMP recommends third indication for darolutamide
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100